It has been found that AGAP2-AS1 is critically implicated in GBM development and progression by targeting miR-15a/b-5p and upregulation of β-catenin and cyclinD1 in the canonical Wnt axis (Zheng et al., 2019[68]). Here, AGAP2 is linked to glioblastoma.